Collectively, DCDC2 is frequently over-expressed in ICC and serves as an ICC-distinctive antigen, which may both be used as biomarkers for the diagnosis of ICC, acompanying with its priority in prognosis prediction for ICC. The gene discussed is DCDC2; the disease is intrahepatic cholangiocarcinoma.